Health
US doubles spending on potential virus vaccine to nearly US$1 billion – CNA
The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 27) begins the decisive final phase of clinical trials.
WASHINGTON: The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 27) begins the decisive final phase of clinical trials.
The government now plans to spend up to US$472 million on top of the previously announced US$483 million, the Moderna biotechnology company announced Sunday.
Advertisement
Advertisement
Moderna said the added investment was justified by its decision, in…
Continue Reading